MENLO PARK, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today announced the completion...
Principal investigator Dr. Jaime Guevara Aguirre, world-renowned expert on growth hormone to conduct the trial of Altsulin® (Microencapsulated Sertoli Cells) in Laron Syndrome Patients Laron Syndrome (aka Laron-type dwarfism) is a rare pediatric orphan disease...
– Over 700 patients enrolled in the T2 Protect AD Study evaluating troriluzole in symptomatic treatment of mild-to-moderate Alzheimer’s disease – Secondary and exploratory measures to assess if troriluzole can protect against, slow down, and...
ST. PAUL, Minn.–(BUSINESS WIRE)– Spineology Inc., an innovator in anatomy-conserving spine surgery, is pleased to announce that John Chi, M.D., MPH, Associate Professor of Neurosurgery at Harvard Medical School and the Director of Neurosurgical Spinal...
PRINCETON, N.J., Nov. 05, 2019 (GLOBE NEWSWIRE) — Vyome Therapeutics, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announced the completion of enrollment of 471...
— RRx-001 is a small molecule immunotherapy targeting CD47 – SIRPα that repolarizes tumor associated macrophages — LA JOLLA, Calif.–(BUSINESS WIRE)–EpicentRx, Inc., a clinical cancer immunotherapy company targeting both sides of the immune...
Email
Text